INTRODUCTION: Psychomotor agitation is a common event in psychiatric emergency services (PES) with a prevalence of approximately 10 %. There is no general consensus on to how to manage psychomotor agitation; benzodiazepines, typical antipsychotics and now atypical antipsychotics have demonstrated similar efficacy. The aim of our study was to describe the epidemiology and clinical management of agitation in "real-life" in a psychiatric emergency service. METHODS: A naturalistic study was performed in acutely agitated patients recruited consecutively in a psychiatric emergency service. Demographics, clinical and therapeutic characteristics were analyzed. Efficacy was assessed by the Excitement Component of the Positive and Negative Syndrome Scale (PANSS-EC) and the Agitation-Calmness Evaluation Scale (ACES). Pragmatic variables such as the need for second pharmacological intervention and the need for physical restraints were assessed. RESULTS: The study included 100 patients with psychomotor agitation. Mean age was 36.2 % and 54% were women. The most prevalent diagnoses were psychotic disorder (48 %) and personality disorder (24 %). Physical restraint was required in 39 % of patients and 52 % accepted oral treatment. Haloperidol was the most frequent oral treatment and olanzapine was the most frequent intramuscular treatment. CONCLUSIONS: A naturalistic approach provides data based on clinical reality in psychiatric emergency services. Strict research designs of clinical trials of efficacy imply sample selection biases and are generally distanced from the clinical reality. Atypical antipsychotics have become the first-line treatment in acute agitation
INTRODUCTION:Psychomotor agitation is a common event in psychiatric emergency services (PES) with a prevalence of approximately 10 %. There is no general consensus on to how to manage psychomotor agitation; benzodiazepines, typical antipsychotics and now atypical antipsychotics have demonstrated similar efficacy. The aim of our study was to describe the epidemiology and clinical management of agitation in "real-life" in a psychiatric emergency service. METHODS: A naturalistic study was performed in acutely agitated patients recruited consecutively in a psychiatric emergency service. Demographics, clinical and therapeutic characteristics were analyzed. Efficacy was assessed by the Excitement Component of the Positive and Negative Syndrome Scale (PANSS-EC) and the Agitation-Calmness Evaluation Scale (ACES). Pragmatic variables such as the need for second pharmacological intervention and the need for physical restraints were assessed. RESULTS: The study included 100 patients with psychomotor agitation. Mean age was 36.2 % and 54% were women. The most prevalent diagnoses were psychotic disorder (48 %) and personality disorder (24 %). Physical restraint was required in 39 % of patients and 52 % accepted oral treatment. Haloperidol was the most frequent oral treatment and olanzapine was the most frequent intramuscular treatment. CONCLUSIONS: A naturalistic approach provides data based on clinical reality in psychiatric emergency services. Strict research designs of clinical trials of efficacy imply sample selection biases and are generally distanced from the clinical reality. Atypical antipsychotics have become the first-line treatment in acute agitation
Authors: Alonso Montoya; Amparo Valladares; Luis Lizán; Luis San; Rodrigo Escobar; Silvia Paz Journal: Health Qual Life Outcomes Date: 2011-03-29 Impact factor: 3.186
Authors: Maria Rubio-Valera; Juan V Luciano; José Miguel Ortiz; Luis Salvador-Carulla; Alfredo Gracia; Antoni Serrano-Blanco Journal: BMC Psychiatry Date: 2015-03-04 Impact factor: 3.630
Authors: Luis San; Josef Marksteiner; Peter Zwanzger; María Aragüés Figuero; Francisco Toledo Romero; Grigorios Kyropoulos; Alberto Bessa Peixoto; Roxana Chirita; Anca Boldeanu Journal: Clin Pract Epidemiol Ment Health Date: 2016-10-27
Authors: José Martínez-Raga; Mario Amore; Guido Di Sciascio; Radu Ioan Florea; Marina Garriga; Gabriel Gonzalez; Kai G Kahl; Per-Axel Karlsson; Jens Kuhn; Maria Margariti; Bruno Pacciardi; Konstantinos Papageorgiou; Maurizio Pompili; Fabrice Rivollier; Ángel Royuela; Gemma Safont; Joachim Scharfetter; Bo Skagen; Kazuhiro Tajima-Pozo; Pierre Vidailhet Journal: Front Psychiatry Date: 2018-02-27 Impact factor: 4.157
Authors: Leonardo Baldaçara; Flávia Ismael; Verônica Leite; Lucas A Pereira; Roberto M Dos Santos; Vicente de P Gomes Júnior; Elie L B Calfat; Alexandre P Diaz; Cintia A M Périco; Deisy M Porto; Carlos E Zacharias; Quirino Cordeiro; Antônio Geraldo da Silva; Teng C Tung Journal: Braz J Psychiatry Date: 2018-12-06 Impact factor: 2.697
Authors: Maurizio Pompili; Giuseppe Ducci; Alessandro Galluzzo; Gianluca Rosso; Claudia Palumbo; Domenico De Berardis Journal: Int J Environ Res Public Health Date: 2021-04-20 Impact factor: 3.390